288 related articles for article (PubMed ID: 26996196)
1. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
[TBL] [Abstract][Full Text] [Related]
2. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
Miskowiak KW; Macoveanu J; Vinberg M; Assentoft E; Randers L; Harmer CJ; Ehrenreich H; Paulson OB; Knudsen GM; Siebner HR; Kessing LV
Acta Psychiatr Scand; 2016 Sep; 134(3):249-59. PubMed ID: 27259062
[TBL] [Abstract][Full Text] [Related]
3. Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder.
Miskowiak KW; Petersen NA; Harmer CJ; Ehrenreich E; Kessing LV; Vinberg M; Macoveanu J; Siebner HR
Acta Psychiatr Scand; 2018 Oct; 138(4):336-347. PubMed ID: 29882276
[TBL] [Abstract][Full Text] [Related]
4. Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial.
Miskowiak KW; Forman JL; Vinberg M; Siebner HR; Kessing LV; Macoveanu J
J Psychiatry Neurosci; 2020 May; 45(3):198-205. PubMed ID: 31804779
[TBL] [Abstract][Full Text] [Related]
5. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
Trials; 2010 Oct; 11():97. PubMed ID: 20942940
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
Miskowiak K; Inkster B; O'Sullivan U; Selvaraj S; Goodwin GM; Harmer CJ
Exp Brain Res; 2008 Jan; 184(3):313-21. PubMed ID: 17828390
[TBL] [Abstract][Full Text] [Related]
12. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
[TBL] [Abstract][Full Text] [Related]
13. Altered prefrontal cortex activity during working memory task in Bipolar Disorder: A functional Magnetic Resonance Imaging study in euthymic bipolar I and II patients.
Dell'Osso B; Cinnante C; Di Giorgio A; Cremaschi L; Palazzo MC; Cristoffanini M; Fazio L; Dobrea C; Avignone S; Triulzi F; Bertolino A; Altamura AC
J Affect Disord; 2015 Sep; 184():116-22. PubMed ID: 26074021
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
[TBL] [Abstract][Full Text] [Related]
15. The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
Vinberg M; Miskowiak K; Hoejman P; Pedersen M; Kessing LV
PLoS One; 2015; 10(5):e0127629. PubMed ID: 26011424
[TBL] [Abstract][Full Text] [Related]
16. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.
Smith J; Browning M; Conen S; Smallman R; Buchbjerg J; Larsen KG; Olsen CK; Christensen SR; Dawson GR; Deakin JF; Hawkins P; Morris R; Goodwin G; Harmer CJ
Mol Psychiatry; 2018 May; 23(5):1127-1133. PubMed ID: 28533517
[TBL] [Abstract][Full Text] [Related]
17. Associations between aberrant working memory-related neural activity and cognitive impairments in somatically healthy, remitted patients with mood disorders.
Macoveanu J; Petersen JZ; Fisher PM; Kessing LV; Knudsen GM; Miskowiak KW
Psychol Med; 2023 Nov; 53(15):7203-7213. PubMed ID: 37051904
[TBL] [Abstract][Full Text] [Related]
18. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
[TBL] [Abstract][Full Text] [Related]
19. A pilot investigation of differential neuroendocrine associations with fronto-limbic activation during semantically-cued list learning in mood disorders.
Peters AT; Smith RA; Kassel MT; Hagan M; Maki P; Van Meter A; Briceño EM; Ryan KA; Weldon AL; Weisenbach SL; Starkman MN; Langenecker SA
J Affect Disord; 2018 Oct; 239():180-191. PubMed ID: 30014958
[TBL] [Abstract][Full Text] [Related]
20. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
Ott CV; Vinberg M; Kessing LV; Miskowiak KW
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
